BIPIX ProFunds Biotechnology UltraSector Inv Forecast, Technical & Fundamental Analysis

The most notable companies in this group are Sarepta Therapeutics (NASDAQ:SRPT).

The investment seeks daily investment results, before fees and expenses, that correspond to one and one-half times (1.5x) the daily performance of the S&P Biotechnology Select Industry Index. The fund invests in financial instruments that the fund advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index represents the biotechnology segment of the S&P Total Market Index, which comprises the following sub-industry: biotechnology. The fund is non-diversified.

The average market capitalization across the ProFunds Biotechnology UltraSector Inv MF is 63.9B. The market cap for tickers in the group ranges from 3.55B to 13.95B. SRPT holds the highest valuation in this group at 13.95B. The lowest valued company is BHVN at 3.55B.

The average weekly volume growth across all stocks in the ProFunds Biotechnology UltraSector Inv MF was -13%. For the same stocks of the MF, the average monthly volume growth was -54% and the average quarterly volume growth was -33%